| Model Number |
PRB35-06-200-120 |
| Medical Device Problem Codes |
Activation, Positioning or Separation Problem (2906); Detachment of Device or Device Component (2907); Material Deformation (2976)
|
| Health Effect - Clinical Code |
Insufficient Information (4580)
|
| Date of Event |
03/08/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
A protege ef self-expanding stent was being implanted for the treatment of a 180mm calcified lesion with 80% stenosis in the mid left superficial femoral artery.There was mild tortuosity and moderate calcification.The vessel diameter was 6mm.A 7fr sheath and a 0.014 non medtronic wire.The device was prepped as per the ifu with no issues identified.The lesion was pre-dilated with a 6mm dilation device.Lock-pin was checked for securement.The lock-pin was not removed.The device passed through a previously deployed stent.It was reported partial deployment occurred the proximal stent deployed in the sheath, when the sheath was pulled back the stent was stuck on the sheath and elongated.The stent broke as well as the tip of delivery system.Sheath was removed with stent parts in it.Excessive force was used during withdrawal.No damage to vessel.A new stent was deployed within elongated stent.No patient injury reported for this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Product analysis the device was received with the tip detached and the proximal end of the stent stuck in the device approximately 12mm of the distal end of the stent returned a set of witness marks were noted on the stainless steel hypotube approximately 27mm and 29mm from the distal end of the stainless steel hypotube; indicating that the safety locking pin was properly tightened during manufacturing.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Search Alerts/Recalls
|